172 related articles for article (PubMed ID: 15727005)
21. Towards harmonization: the European biotechnology patent directive.
Curley D
J Biolaw Bus; 2002; 5(3):64-8. PubMed ID: 12816122
[TBL] [Abstract][Full Text] [Related]
22. The patentability of human-animal chimeras.
Magnani TA
Berkeley Technol Law J; 1999; 14():443-60. PubMed ID: 15732205
[No Abstract] [Full Text] [Related]
23. Opinion on Directive 98/44/EC on the legal protection of biotechnical inventions, and its implementation in Sweden.
Swedish National Council on Medical Ethics
Sci Eng Ethics; 2005 Jan; 11(1):113-5. PubMed ID: 15729767
[TBL] [Abstract][Full Text] [Related]
24. Debate on patentability of biotechnological studies in Turkey.
Memiş T
Rev Derecho Genoma Hum; 2007; (26):121-35. PubMed ID: 18201040
[TBL] [Abstract][Full Text] [Related]
25. Patenting, morality and human embryonic stem cell science: bioethics and cultural politics in Europe.
Salter B
Regen Med; 2007 May; 2(3):301-11. PubMed ID: 17511566
[TBL] [Abstract][Full Text] [Related]
26. Human gene patents: core issues in a multi-layered debate.
Hoedemaekers R
Med Health Care Philos; 2001; 4(2):211-21. PubMed ID: 11547507
[TBL] [Abstract][Full Text] [Related]
27. Are natural gene sequences patentable?
Becker KB
Int Arch Occup Environ Health; 2000 Jun; 73 Suppl():S19-22. PubMed ID: 10968555
[TBL] [Abstract][Full Text] [Related]
28. Bioethics, biotechnology products and humans: Europe between the skilled Theseus and the Labyrinth-Minotaur's syndrome.
Frati P
Forum (Genova); 1999; 9(3 Suppl 3):99-105. PubMed ID: 10607854
[TBL] [Abstract][Full Text] [Related]
29. Alienation from the Objectives of the Patent System: How to Remedy the Situation of Biotechnology Patent.
Jiang L
Sci Eng Ethics; 2019 Jun; 25(3):791-811. PubMed ID: 29532279
[TBL] [Abstract][Full Text] [Related]
30. Patents on inventions related to human embryonic stem cells: the morality clause after Brüstle v. Greenpeace.
Panis S
Med Law; 2013 Sep; 32(3):347-72. PubMed ID: 24340486
[TBL] [Abstract][Full Text] [Related]
31. Exploiting abstract possibilities: a critique of the concept and practice of product patenting.
Radder H
J Agric Environ Ethics; 2004; 17(3):275-91. PubMed ID: 15543679
[TBL] [Abstract][Full Text] [Related]
32. The patentability of human beings: the effect of a proposed exclusion in the Patents Act 1953.
MacBean A
Law Rev; 2002 Nov; 33(2):379-407. PubMed ID: 15212079
[TBL] [Abstract][Full Text] [Related]
33. [Genetic comment on patenting of biotechnology inventions in the adaptation of the Spanish Patenting Law to the European framework].
Lacadena JR
Rev Derecho Genoma Hum; 2002; (16):199-221. PubMed ID: 12379987
[TBL] [Abstract][Full Text] [Related]
34. The attack of the clones: patent law and stem cell research.
Rimmer M
J Law Med; 2003 May; 10(4):488-505. PubMed ID: 12852321
[TBL] [Abstract][Full Text] [Related]
35. Intellectual property and biotechnology: the European debate.
Brody B
Kennedy Inst Ethics J; 2007 Jun; 17(2):69-110. PubMed ID: 18018994
[TBL] [Abstract][Full Text] [Related]
36. Locating gene patents within the patent system.
Rai AK
Am J Bioeth; 2002; 2(3):18-9. PubMed ID: 12230845
[No Abstract] [Full Text] [Related]
37. Genomic patenting and the utility requirement.
Calvert J
New Genet Soc; 2004 Dec; 23(3):301-12. PubMed ID: 15828153
[TBL] [Abstract][Full Text] [Related]
38. Second medical use in Turkey.
Baklaci E; Altınay M
Pharm Pat Anal; 2016 Jul; 5(4):199-201. PubMed ID: 27334394
[TBL] [Abstract][Full Text] [Related]
39. Adapting the ordre public and morality exclusion of European patent law to accommodate emerging technologies.
Pila J
Nat Biotechnol; 2020 May; 38(5):555-557. PubMed ID: 32393908
[No Abstract] [Full Text] [Related]
40. [Patent rights and biotechnological inventions].
Lobato García-Miján M
Rev Derecho Genoma Hum; 1998; (9):143-61. PubMed ID: 10335339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
